The content on this site is intended for healthcare professionals only
Dr Gil Morgan from OncoAlert gives his oncology highlights from social media for the week of September 20th - September 26th.
Dr Morgan starts the video by congratulating ESMO on their virtual meeting and highlights some of the studies presented.
Dr Morgan covers papers from Clinical Cancer Research, Cancer Medicine, The Lancet Oncology, JNCI and Nature Cancer on a breadth of cancer types as well as general patient care.
He also draws attention to new guidelines that have been released and #WorldCancerResearchDay
Dr Morgan closes by announcing the OncoAlert Colloquium - a two-day event on practice-changing oncology findings in each tumour type taught by OncoAlert faculty.
Follow Dr Morgan on twitter: @OncoAlert
Follow ecancer on twitter: @ecancer
Prostate cancer
Addressing Breast Cancer Disparities in Africa
Cancer in emergencies: What can we do better to protect the most vulnerable?
Grand Rounds: Improving quality of patient-centred care
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
Supporting breast cancer patients in Vietnam
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer
Tusamitamab ravtansine combined with SoC shows encouraging anti-tumour activity for patients with nonsquamous NSCLC
T-DXd demonstrates high levels of efficacy in patients with HER2+ unresectable and/or mBC previously treated with T-DM1
